SAGE
Sage Therapeutics, Inc. - Common Stock (SAGE)
$63
About Sage Therapeutics, Inc. - Common Stock (SAGE)
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.
Details
Daily high
$6.74
Daily low
$6.56
Price at open
$6.74
52 Week High
$13.47
52 Week Low
$4.62
Market cap
423.9M
Dividend yield
0.00%
Volume
220,614
Avg. volume
709,418
P/E ratio
-1.17
Sage Therapeutics, Inc. - Common Stock News
Details
Daily high
$6.74
Daily low
$6.56
Price at open
$6.74
52 Week High
$13.47
52 Week Low
$4.62
Market cap
423.9M
Dividend yield
0.00%
Volume
220,614
Avg. volume
709,418
P/E ratio
-1.17